We are live on ! Find out more
ONCE

Spark Therapeutics, Inc. Common Stock
ONCE

Delisted

ONCE was delisted on the 16th of December, 2019.

Back to rankings

160 hedge funds and large institutions have $1.92B invested in Spark Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $33.3M | Put options by funds: $17.5M

85% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

6% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 47

2% less funds holding

Funds holding: 163 → 160 (-3)

39% less capital invested

Capital invested by funds: $3.15B → $1.92B (-$1.23B)

Holders
160
Holders Change
-3
Holders Change %
-1.84%
% of All Funds
3.63%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
44
Increased
61
Reduced
33
Closed
47
Calls
$33.3M
Puts
$17.5M
Net Calls
+$15.8M
Net Calls Change
+$18.4M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$161M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$39.4M
3
GPP
Great Point Partners
Connecticut
+$29.5M
4
JP Morgan Chase
JP Morgan Chase
New York
+$28.1M
5
RFS
Rockefeller Financial Services
New York
+$25.3M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$55.1M
2
Deutsche Bank
Deutsche Bank
Germany
-$54.9M
3
O
OrbiMed
New York
-$38.3M
4
LCM
Laurion Capital Management
New York
-$34.7M
5
Jennison Associates
Jennison Associates
New York
-$27.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
IPLA
26
Ice Pond Lane Advisers
New York
$10.9M – – –
Deutsche Bank
27
Deutsche Bank
Germany
$9.3M -$54.9M -764,586 -81%
Macquarie Group
28
Macquarie Group
Australia
$9.01M +$12.6M +175,270 New
Norges Bank
29
Norges Bank
Norway
$8.97M – – –
PAMU
30
Pictet Asset Management (UK)
United Kingdom
$8.92M +$3.01M +41,919 +32%
Ameriprise
31
Ameriprise
Minnesota
$8.84M -$2.55M -35,536 -17%
SIM
32
Spark Investment Management
New York
$8.83M +$12.3M +171,800 New
Morgan Stanley
33
Morgan Stanley
New York
$8.81M +$7.77M +108,100 +171%
ECM
34
Element Capital Management
New York
$8.02M +$11.2M +155,988 New
Charles Schwab
35
Charles Schwab
California
$7.44M +$1.08M +15,062 +12%
UBS AM
36
UBS AM
Illinois
$7.4M +$458K +6,378 +5%
NI
37
Numeric Investors
Massachusetts
$7.39M +$10.3M +143,800 New
IA
38
IPL Advisers
New York
$7.38M – – –
CS
39
Credit Suisse
Switzerland
$7.36M +$5.44M +75,701 +112%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$6.88M -$1.37M -19,020 -12%
Group One Trading
41
Group One Trading
Illinois
$5.98M +$8.36M +116,321 New
Massachusetts Financial Services
42
Massachusetts Financial Services
Massachusetts
$5.97M +$110K +1,535 +1%
SM
43
Sabby Management
Florida
$5.7M +$7.96M +110,827 New
Axa
44
Axa
France
$5.19M -$252K -3,512 -3%
SFM
45
Sphera Funds Management
Israel
$5.14M +$7.18M +100,000 New
Fidelity International
46
Fidelity International
Bermuda
$4.49M +$1.43M +19,953 +30%
AAMU
47
Amundi Asset Management US
Massachusetts
$4.38M +$1.85M +25,808 +44%
TD Asset Management
48
TD Asset Management
Ontario, Canada
$4.37M +$353K +4,915 +6%
QIM
49
Quantitative Investment Management
Virginia
$4.29M -$2.63M -36,600 -31%
SAM
50
Sectoral Asset Management
Quebec, Canada
$4.29M -$2.39M -33,209 -28%
1
2
3 4 5

ONCE Hedge Fund Activity: Q4 2017 in Review

160 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Spark Therapeutics, Inc. Common Stock (ONCE) for Q4 2017, worth a combined $1.92B — down 39% from $3.15B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ONCE and 44 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 61 added.

The largest buyer was Wellington Management Group, adding an estimated $161M. The largest seller was Lord, Abbett & Co, cutting an estimated $55.1M.

  • 160 institutional investors held Spark Therapeutics, Inc. Common Stock (ONCE) as of Q4 2017, down from 163 in Q3 2017.
  • Funds reported $1.92B of Spark Therapeutics, Inc. Common Stock stock for Q4 2017, down 39% quarter-over-quarter.
  • 44 funds opened new Spark Therapeutics, Inc. Common Stock positions in Q4 2017 and 47 closed out, a net change of -3 holders.
  • The largest Spark Therapeutics, Inc. Common Stock buyer in Q4 2017 was Wellington Management Group, an estimated $161M added.
  • The largest Spark Therapeutics, Inc. Common Stock seller in Q4 2017 was Lord, Abbett & Co, an estimated $55.1M sold.

Based on aggregated 13F filings for Q4 2017.